国药一致

- 000028

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
国药一致(000028) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入1,909,048.087,547,748.465,658,586.453,838,753.151,868,681.78
营业收入1,909,048.087,547,748.465,658,586.453,838,753.151,868,681.78
二、营业总成本1,862,847.597,327,709.705,498,123.333,724,725.681,816,684.12
营业成本1,701,709.706,642,542.565,004,717.133,393,679.551,655,351.58
营业税金及附加4,547.7318,817.9513,914.619,056.584,265.86
销售费用126,240.13532,595.21384,354.94260,339.96126,102.49
管理费用25,165.22110,618.3680,930.5853,070.0426,524.21
财务费用4,558.7920,453.5112,410.227,375.894,217.01
研发费用626.022,682.111,795.851,203.66222.98
资产减值损失----------
公允价值变动收益---1,516.111,742.911,742.91--
投资收益10,273.7223,702.9422,706.2915,566.588,771.27
其中:对联营企业和合营企业的投资收益11,033.6231,544.6023,245.1515,692.027,747.59
汇兑收益----------
三、营业利润54,400.11246,742.52182,292.32129,511.3257,635.31
加:营业外收入815.072,445.27913.96592.56343.71
减:营业外支出190.251,865.131,161.00938.45130.31
其中:非流动资产处置损失----------
四、利润总额55,024.93247,322.65182,045.29129,165.4357,848.71
减:所得税费用10,412.6251,473.9437,025.8026,224.8811,765.64
五、净利润44,612.31195,848.71145,019.49102,940.5546,083.08
归属于母公司所有者的净利润38,877.07159,925.58118,966.3683,025.1136,220.53
少数股东损益5,735.2435,923.1326,053.1219,915.449,862.54
六、每股收益
基本每股收益(元/股)0.70002.87002.14001.49000.8500
稀释每股收益(元/股)0.70002.87002.14001.49000.8500
七、其他综合收益--5.63-0.98-0.98-0.48
八、综合收益总额44,612.31195,854.34145,018.50102,939.5746,082.60
归属于母公司所有者的综合收益总额38,877.07159,929.38118,965.3883,024.1236,220.06
归属于少数股东的综合收益总额5,735.2435,924.9626,053.1219,915.449,862.54
下载全部历史数据到excel中 返回页顶